Melatonin, a pineal hormone with antioxidant property, protects against gentamicin-induced nephrotoxicity in rats

Nephron

Volumn 85, Issue 2, 2000, Pages 167-174

  Shifow, A A ^a   Kumar, K V ^a   Naidu, M U R ^a   Ratnakar, K S ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antioxidant; Gentamicin; Melatonin; Nephrotoxicity

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ANTIOXIDANT; CREATININE; GENTAMICIN; GLUCOSE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MELATONIN; N ACETYL BETA GLUCOSAMINIDASE; PINEAL BODY HORMONE; PROTEIN; SUPEROXIDE DISMUTASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; GLUCOSE URINE LEVEL; GRANULATION TISSUE; HISTOLOGY; KIDNEY CORTEX; KIDNEY TUBULE CELL; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UREA BLOOD LEVEL;

EID: 0034038385     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045650     Document Type: Article

References (58)

1. Humes HD, Weinberg JM: Toxic nephropathies; in Brenner BM, Rector FC Jr (eds): The Kidney. Philadelphia, Saunders, 1986, pp 1491-1553.
2. Hostetter TH, Brenner BM: Renal circulatory and nephron function in experimental acute renal failure: in Brenner BM, Lazarus JM (eds): Acute Renal Failure, ed 2. New York, Churchill Livingstone, 1988, pp 67-89.
3. Fox RB: Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea. J Clin Invest 1984;74:1456-1464.
4. Weiss JJ, LoBuglio AF: Phagocyte-generated oxygen metabolite and cellular injury. Lab Invest 1982;47:5-18.
5. Varani J, Fligiel SE, Till GO, Kunkel RG, Ryan US, Ward PA: Pulmonary endothelial cell killing by human neutrophils: Possible involvement of hydroxyl radical. Lab Invest 1985;53:656-663.
6. Fantone JC, Ward PA: Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982;107:397-418.
7. Shah SV: Effect of enzymatically generated reactive oxygen metabolites on the cyclic nucleotide content in isolated glomeruli. J Clin Invest 1984;74:393-401.
8. Shah SV, Barcos WH, Basci A: Degradation of human glomerular basement membrane by stimulated neutrophils: Activation of a metalloproteinase(s) by reactive oxygen metabolites. J Clin Invest 1987;79:25-31.
9. Rehan AK, Wiggins RC, Kunkel RG, Till GO, Johnson KH: Glomerular injury and proteinuria in rats after intradermal injection of cobra venon factor. Am J Pathol 1986;123:57-66.
10. Rehan AK, Johnson KJ, Kunkel RG, Wiggins RC: Role of oxygen radicals in phorbol myristate acetate-induced glomerular injury. Kidney Int 1985;7:503-511.
11. Walker PD, Shah SV: Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria. Am J Physiol 1987;253: C495-C499.
12. Ramsammy LS, Josephowitz C, Ling KY, Lane BP, Kaloyanides GJ: Effects of diphenyl-phenylenediamine on gentamicin-induced lipid peroxidation and toxicity in rat renal cortex. J Pharmacol Exp Ther 1986;238:83-88.
13. Wong NL, Magil AB, Dirks JH: Effect of magnesium diet in gentamicin-induced acute renal failure in rats. Nephron 1989;51:84-88.
14. Hayashi T, Watanabe Y, Kumano K, Kitayama R, Yasuda RT, Saikawa I, Katahira J, Kumada T, Shimazu K: Protective effect of piperacillin against nephrotoxicity of cephaloridine and gentamicin in animals. Antimicrob Agents Chemother 1988;3:912-918.
15. Nakakuki M, Yamusaki F, Shinkawa T, Kuda M, Watanabe M, Mizota M: Protective effect of human ulinastatin against gentamicin-induced acute renal failure in rats. Can J Physiol Pharmacol 1996;74:104-111.
16. Lee JM, Pattison ME, Michael UF: Nitrendipine protects against aminoglycoside nephrotoxicity in the rat. J Cardiovasc Pharmacol 1987;9:565-569.
17. Gilbert DN, Wood CA, Kohlepp PW, Houghton DC, Finkbeiner HC, Lindsley J, Bennet WM: Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis 1989;159:945-953.
18. Sandhya P, Mohan Das S, Varalakshmi P: Role of DL-lipoic acid in gentamicin-induced nephrotoxicity. Mol Cell Biol 1995;145:11-17.
19. Walker PD, Shah SV: Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest 1988; 81:334-341.
20. Tan DX, Chan LD, Poeggeler B, Manchester LC, Reiter RJ: A potent, endogenous hydroxyl radical scavenger. Endocr J 1993;1:57-60.
21. Pieri C, Marra M, Morani F, Recchioni R, Marcheselli B: Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci 1994;55:271-276.
22. Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Walden LR: Melatonin - a highly potent endogenous radical scavenger and electron donor: New aspects of the oxidation chemistry of this indole accessed in vitro. Ann NY Acad Sci 1994;738: 419-420.
23. Montilla P, Tuñez I, Muñoz MC, López A, Soria JV: Hyperlipidemic nephropathy induced by Adriamycin: Effect of melatonin administration. Nephron 1997;76:345-350.
24. Morishima I, Matsui H, Mukawa H, Hayashi K, Toki Y, Okumura K, Ito T, Hayakawa T: Melatonin: A pineal hormone with antioxidant property protects against Adriamycin cardiomyopathy in rats. Life Sci 1998;63:511-521.
25. Lakshmi V, Reiter RJ, Meltx ML: Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat Res 1995;346:23-31.
26. Tax DX, Reiter RJ, Chen LD, Poeggeler B, Manchester LC, Barlow-Walden LR: Both physiological and pharmacological levels of melatonin reduced DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 1994;15:215-218.
27. Melchiorri D, Reiter RJ, Attia AM, Hara M. Burgos A, Nistico G: Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1995;56:83-89.
28. Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG, Lewinski A: Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 1995;293:327-334.
29. Li ZR, Reiter RJ, Fujimori O. Oh CS, Duam YD: Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: Preventive actions of melatonin. J Pineal Res 1997;22:117-123.
30. Bertuglia S. Marchiafava PL, Colantuoni A: Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 1996;31:947-952.
31. Pierrefiche G, Topall G, Courboin G, Henriet I, Loborit H: Antioxidant activity of melatonin in mice. Res Commun Chem Pathol Pharmacol 1993;80:211-223.
32. Abdul-Gayom AA, Ali BH, Abdel Razig KM, Bashir AA, Ghywarsha K: Effect of gentamicin-induced nephrotoxicity on some CHO metabolism pathway in the rat renal cortex. Arch Toxicol 1994;68:643-674.
33. Horak E, Hofter SM, Sunderman FW: Spectrophotometric assay for urinary N-acetyl-beta-D-glucosaminidase activity. Clin Chem 1981;27: 1180-1185.
34. Bernheim FM, Bernheim BL, Wilbur KM: The reaction between TBA and the oxidation products of certain lipids. J Biol Chem 1948;174: 257-264.
35. McCord JM, Fridovich I: Superoxide dismutase: An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244(2): 6049-6055.
36. Aebi H: Catalase in vitro. Methods Enzymol 1984;105:121-126.
37. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
38. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
39. Houghton DC, Plamp CE, Defehr JM, Bennett WM, Forter G, Gilbert D: Gentamicin and tobramycin nephrotoxicity: A morphologic and functional comparison in the rat. Am J Pathol 1978;93:137-152.
40. Kacew S: Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5′-phosphate in the rat. J Pharmacol Exp Ther 1989;248:360-367.
41. Ohnishi A. Biryant TD, Branch KR, Sabra R, Branch RA: Role of sodium in the protective effect of ticarcillin on gentamicin nephrotoxicity. Antimicrob Agents Chemother 1989;33: 928-932.
42. Uekama K, Shiotami K, Irie T, Ishimaru Y, Pitha J: Protective effects of cyclodextrin sulphates against gentamicin-induced nephrotoxicity in the rat. J Pharm Pharmacol 1993;45: 745-747.
43. Okasaro T, Takikawa T, Utisumiya Y: Suppressive effect of SOD on Adriamycin nephropathy. Nephron 1992;60:199-203.
44. Washio M, Nanishi F, Onoyama K, Fujishima M: Alpha tocopherol improves focal glomerulosclerosis in rats with Adriamycin-induced progressive renal failure. Nephron 1994;68: 347-352.
45. Kuo CH, Hook JB: Depletion of renal glutathione and nephrotoxicity by cephaloridine, cephalothin and gentamicin in male Sprague-Dawley rats. Life Sci 1982;31:255-260.
46. McMurtry RJ, Snodgran WR, Witchell JR: Renal necrosis, glutathione depletion, and covalent binding after acetaminophen. Toxicol Appl Pharmacol 1978;46:87-100.
47. Reiter RJ, Melchiorri D, Sewrynek E, Poeggeler B, Barlow-Walden LR, Chuang J, Ortiz GG, Acuna-Castro Viejo D: A review of evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995;18:1-11.
48. Ramsammy LS, Josepovitz C, Ling KY, Lane BP, Kaloyanides GJ: Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat. Biochem Pharmacol 1987;36:2125-2132.
49. Paller MS, Moidal JR, Ferriz TF: Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984;74:1156-1164.
50. Naidu MUR, Vijay Kumar K, Shifow AA, Prayag A, Ratnakar KS: Lacidipine protects against cyclosporine-induced nephrotoxicity in rats. Nephron 1999;81:60-66.
51. Kumar KV, Naidu MUR, Shifow AA, Prayag A, Ratnakar KS: Melatonin: An antioxidant protects against cyclosporine-induced nephrotoxicity. Transplantation 1999;67:1065-1068.
52. Barlow-Walden LR, Reiter RJ, Abe M, Pabros M, Menendez-Perez A, Chen LD, Poeggeler B: Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995;26:497-502.
53. Sewerynek E, Abe M, Reiter RJ, Barlow-Walden LR, Chen LD, McCabe JJ, Roman LY, Diaz-López B: Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phenobarbital-treated animals. J Cell Biochem 1995;58:436-444.
54. Poeggeler B, Reiter RJ, Hardeland R, Sewerynek E, Melchiorri D, Barlow-Walden LR: Melatonin, a mediator of electron transfer and repair reactions, acts synergistically with the chain-breaking antioxidants ascorbate, trolox and glutathione. Neuroendocrinol Lett 1995; 17:87-92.
55. Lodhi S, Weiner ND, Schacht J: Interactions of neomycin and phosphoinositide monolayers. Biochem Biophys Acta 1976;426:781-785.
56. Humes HD, Sastrasinn M, Weinberg JM: Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin toxicity. J Clin Invest 1984;73: 134-147.
57. Schwertschlag U, Schrier RW, Wilson P: Beneficial effects of calcium channel blockers and calmodulin binding drugs on in vitro and renal cell anoxia. J Pharmacol Exp Ther 1986;238: 119-124.
58. 2+ stimulated ATPase activity induced by alloxan. Am J Physiol 1994;267:E57-E62.